Gemcitabine, cisplatin, and dexamethasone and ifosfamide, carboplatin, and etoposide regimens have similar efficacy as salvage treatment for relapsed/refractory aggressive lymphoma: A retrospectively comparative study

In this study, our aim was to compare the efficacy and toxicity profiles of gemcitabine, cisplatin, and dexamethasone (GDP) and ifosfamide, carboplatin, and etoposide (ICE) regimens in the salvage treatment of relapsed/refractory lymphoma. A total of 110 patients with refractory/relapsed classical H...

Descripción completa

Detalles Bibliográficos
Autores principales: Mi, Mi, Zhang, Caijiao, Liu, Zijian, Wang, Ye, Li, Juan, Zhang, Liling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717738/
https://www.ncbi.nlm.nih.gov/pubmed/33285732
http://dx.doi.org/10.1097/MD.0000000000023412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717738/
https://www.ncbi.nlm.nih.gov/pubmed/33285732
http://dx.doi.org/10.1097/MD.0000000000023412

Ejemplares similares